about
Guidance in social and ethical issues related to clinical, diagnostic care and novel therapies for hereditary neuromuscular rare diseases: "translating" the translationalRNA and diseaseA novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies.Transgenic overexpression of LARGE induces α-dystroglycan hyperglycosylation in skeletal and cardiac muscleA human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophyMuscle histology vs MRI in Duchenne muscular dystrophy.Duchenne muscular dystrophy: current cell therapiesA mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy.Strategies for manufacturing recombinant adeno-associated virus vectors for gene therapy applications exploiting baculovirus technology.AAV-directed muscular dystrophy gene therapy.Plant biofarming: novel insights for peptide expression in heterologous systems.Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy.Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy.Gene therapy in monogenic congenital myopathies.Magnetic Resonance Monitoring of Disease Progression in mdx Mice on Different Genetic Backgrounds.Dystrophin immunity in Duchenne's muscular dystrophy.Genetic engineering in athletes.Respiratory management strategies for Duchenne muscular dystrophy: practice variation amongst Canadian sub-specialists.A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy.G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy.Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience.
P2860
Q28485060-B10D0AB6-7512-46A8-A276-EC40081A3935Q29615183-F53AF434-013F-4FEE-8C17-F3B79ECA0AD0Q33387968-55F03482-6E0E-42C7-89CF-85E0B90E91E2Q33784310-43F14763-B429-43FC-9847-D8051E3FED22Q34175938-07E6D316-A8A8-4FC7-A6C5-2DA84EBECD42Q34555462-E5928F82-1965-4E54-80FE-B8605CB3641CQ35780806-173AAD63-F368-43CE-81AB-99EE4DB46DDBQ36116720-D367264D-9E27-42C2-BBA8-2C395AA0BBD6Q36925619-A2F65091-CDB2-4E5D-AAFC-9690BF4D3E5DQ37687423-005B89FA-C458-4512-8543-92337A19B8ECQ38063510-E0CF9B35-9C71-4616-A8EF-D09820D5BBA6Q38115148-1BE45058-D3AD-48DF-BB97-7F66FCF9EC40Q38168509-3CE2847D-6D7E-4EC6-83D5-549F3E182AECQ38603658-B30CFE9A-3B84-4A0C-9BEA-943185E0B27AQ38615889-3C97DC47-D77D-4189-8EDF-9EA8627F1D11Q41590387-45A0E1BC-A76F-494B-BC53-030319BFA485Q42752947-C0E2F5A8-AB04-45FC-B2C9-19113FED73F0Q43807364-3A6ED7EA-1910-4EE0-92A0-14604FED9C78Q45071049-8BDC12A9-850D-44FE-A531-41FBE550B180Q48203047-326DDD69-1F57-406F-AC13-A4A5D3C47FA8Q51502053-0CE32A8D-D23E-4243-B092-88DF930F3158
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Genetic treatments in muscular dystrophies.
@en
type
label
Genetic treatments in muscular dystrophies.
@en
prefLabel
Genetic treatments in muscular dystrophies.
@en
P1476
Genetic treatments in muscular dystrophies.
@en
P2093
Francesco Muntoni
P304
P356
10.1097/WCO.0B013E3282EFC157
P577
2007-10-01T00:00:00Z